Dr. Joshua A. Sloan, DO

Dr. Sloan practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Sloan's NPI, 1114289873, was assigned on June 8, 2012. Dr. Sloan graduated from Philadelphia College of Osteopathic Medicine in 2012. Dr. Sloan holds Minnesota license 66931.

Dr. Sloan's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Sloan's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Sloan to 7 more group practices and clinics, 7 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sloan practices, 9 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Sloan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Sloan's licenses on file in 3 states: Minnesota, Maryland and Pennsylvania.

CMS data shows 252 Medicare services from Dr. Sloan across 10 procedure codes in 2024, for 171 Medicare patients. Medicare paid $28,822 for them.

CMS counts 171 Medicare patients who saw Dr. Sloan in 2024. The largest group is 65 to 74, with 84 patients. 68% of them have high blood pressure, and 58% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sloan's median patient age at 53, with 59% women.

In 2024, Dr. Sloan wrote 229 Medicare Part D claims for 85 patients. 90% of them were for generic drugs. CMS names the drug for 164 of them, across 4 drugs with 11 or more claims each, at $4,138 in total drug cost. In 2023, CMS named 151 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Sloan for performance year 2024, reported as part of a group. Dr. Sloan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sloan as offering telehealth. CMS counts 105 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Sloan, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Sloan, published from 2015 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Esophageal Motility Disorders, Manometry and Esophageal Achalasia. Dr. Sloan has published most often in Ann N Y Acad Sci. Dr. Sloan's most frequent co-authors are Chandra Prakash Gyawali, MD, Mouen A. Khashab, MD and Elizabeth Stanton Teter Aby, MD.

CMS Open Payments shows 99 general payments to Dr. Sloan from 11 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Sanofi and Genzyme US Companies paid the most, $97,529.

Dr. Sloan graduated from Philadelphia College of Osteopathic Medicine in 2012.